Doctor profile · Federal record
Dr. Nancy Smith, ANP
Adult Health Nurse Practitioner (CMS: Nurse Practitioner) · Fort Worth, TX
- NPI 1326338542
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 22 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2801 S Hulen St Ste 400
Fort Worth, TX 761091528
(817) 921-2838
fax (817) 921-2833
Credentials & registration
- NPI registered
- April 2011 — 15 yrs on file
- Profile last updated
- August 8, 2017
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 363LA2200X — NUCC code
- State license (1)
- Texas #619058
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1326338542. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,400
Distinct HCPCS
10
Medicare allowed
$125,996
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 898 | 150 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 481 | 356 | $76 | |
17000 |
Destruction of precancer skin growth, 1 growth | 296 | 203 | $48 | |
11102 |
Biopsy of related skin growth, first growth | 200 | 160 | $82 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 173 | 130 | $107 | |
17110 |
Destruction of skin growth, 1-14 growths | 126 | 108 | $97 | |
11103 |
Biopsy of related skin growth, each additional growth | 60 | 37 | $43 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 52 | 52 | $95 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 39 | 38 | $48 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 22 | 22 | $141 |
In context: peer comparison
Among 13 peers in this city , average services per provider: 94. This provider delivers 26× the peer median.Open Payments
Industry payments received
All-time total
$1,973
Transactions
83
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 15 | $381.87 | |
| Novartis Pharmaceuticals Corporation | 9 | $224.61 | |
| GENZYME CORPORATION | 7 | $211.48 | |
| Lilly USA, LLC | 6 | $204.83 | |
| Regeneron Healthcare Solutions, Inc. | 12 | $184.68 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $181.76 | |
| Almirall LLC | 3 | $77.17 | |
| Janssen Biotech, Inc. | 4 | $76.81 | |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $69.03 | |
| Incyte Corporation | 3 | $67.02 | |
| UCB, Inc. | 3 | $53.69 | |
| LEO Pharma Inc. | 3 | $49.40 | |
| Galderma Laboratories, L.P. | 3 | $47.26 | |
| Dermavant Sciences, Inc. | 2 | $34.98 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $29.88 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
321
Patients
185
Total drug cost
$8,132
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 101 | 49 | $2,027 |
| Doxycycline Hyclate | Generic | 73 | 33 | $1,602 |
| Triamcinolone Acetonide | Generic | 45 | 39 | $455 |
| Mupirocin | Generic | 34 | 27 | $330 |
| Clobetasol Propionate | Generic | 30 | 21 | $1,480 |
| Fluorouracil | Generic | 21 | 16 | $1,647 |
| Ciclopirox | Generic | 17 | 0 | $591 |
Frequently asked questions
What is Dr. Nancy Smith's medical specialty?
Dr. Nancy Smith practices Adult Health Nurse Practitioner in Fort Worth, TX.
Where does Dr. Nancy Smith practice?
Dr. Nancy Smith practices at 2801 S Hulen St Ste 400, Fort Worth, TX 761091528. Office phone: 8179212838.
What is Dr. Nancy Smith's NPI?
Dr. Nancy Smith's National Provider Identifier (NPI) is 1326338542, issued by NPPES.
Does Dr. Nancy Smith accept Medicare assignment?
Yes. Dr. Nancy Smith accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Nancy Smith commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.